[go: up one dir, main page]

FI922695L - Derivat av amidanalogier av vissa kinoliziner innehaollande en metanobryggbindning - Google Patents

Derivat av amidanalogier av vissa kinoliziner innehaollande en metanobryggbindning Download PDF

Info

Publication number
FI922695L
FI922695L FI922695A FI922695A FI922695L FI 922695 L FI922695 L FI 922695L FI 922695 A FI922695 A FI 922695A FI 922695 A FI922695 A FI 922695A FI 922695 L FI922695 L FI 922695L
Authority
FI
Finland
Prior art keywords
metanobryggbindning
kinoliziner
amidanalogier
vissa
innehaollande
Prior art date
Application number
FI922695A
Other languages
English (en)
Other versions
FI112866B (fi
FI922695A0 (fi
Inventor
Maurice Ward Gittos
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI922695A0 publication Critical patent/FI922695A0/fi
Publication of FI922695L publication Critical patent/FI922695L/fi
Application granted granted Critical
Publication of FI112866B publication Critical patent/FI112866B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/16Central respiratory analeptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Addiction (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI922695A 1991-06-11 1992-06-10 Menetelmä uusien, terapeuttisesti käyttökelpoisten, heksahydro-8-hydroksi-2,6-metano-2H-kinolitsiinien amidijohdannaisten valmistamiseksi sekä menetelmässä käytettävät välituotteet FI112866B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91401550 1991-06-11
EP91401550A EP0517984A1 (en) 1991-06-11 1991-06-11 Derivatives of amide analogs of certain methano bridged quinolizines

Publications (3)

Publication Number Publication Date
FI922695A0 FI922695A0 (fi) 1992-06-10
FI922695L true FI922695L (fi) 1992-12-12
FI112866B FI112866B (fi) 2004-01-30

Family

ID=8208580

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922695A FI112866B (fi) 1991-06-11 1992-06-10 Menetelmä uusien, terapeuttisesti käyttökelpoisten, heksahydro-8-hydroksi-2,6-metano-2H-kinolitsiinien amidijohdannaisten valmistamiseksi sekä menetelmässä käytettävät välituotteet

Country Status (16)

Country Link
EP (2) EP0517984A1 (fi)
JP (1) JP3377227B2 (fi)
KR (1) KR100234926B1 (fi)
AT (1) ATE214392T1 (fi)
AU (1) AU649836B2 (fi)
CA (1) CA2070573C (fi)
DE (1) DE69232473T2 (fi)
DK (1) DK0518767T3 (fi)
ES (1) ES2173863T3 (fi)
FI (1) FI112866B (fi)
HU (1) HU212735B (fi)
IE (1) IE921874A1 (fi)
IL (1) IL102132A (fi)
NO (1) NO305124B1 (fi)
NZ (1) NZ243031A (fi)
PT (1) PT518767E (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU675060B2 (en) * 1992-02-24 1997-01-23 Aventisub Ii Inc. 2,6-methano-2H-quinolizin derivative as 5-HT3-receptor antagonist
US5508287A (en) * 1992-02-24 1996-04-16 Merrell Pharmaceuticals Inc. 2,6-methano-2H-quinolizin derivative as 5-HT3 -receptor antagonist
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
GB9304500D0 (en) * 1993-03-05 1993-04-21 Glaxo Spa Heterocyclic compounds
GB9406857D0 (en) * 1994-04-07 1994-06-01 Sandoz Ltd Improvements in or relating to organic compounds
FR2765107B1 (fr) * 1997-06-26 2000-03-24 Sanofi Sa Utilisation d'un antagoniste specifique des recepteurs 5ht2 pour la preparation de medicaments utiles dans le traitement du syndrome d'apnee du sommeil
BR9815098A (pt) * 1997-11-14 2000-10-10 Akzo Nobel Nv Uso de mirtazapina ou de um seu sal farmaceuticamente aceitável, e, processo para o tratamento de apnéias do sono em um aninal.
DE69931042T2 (de) 1998-02-27 2006-11-23 The Board Of Trustees Of The University Of Illinois, Urbana Stoffe mit serotoninartiger wirkung zur behandlung der schlafapnoe
US7160898B2 (en) 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
JP2005510492A (ja) 2001-10-26 2005-04-21 ユニバーシティ オブ コネチカット 新規な種類の効力のあるカンナビミメティックリガンド
JP2008524332A (ja) 2004-12-20 2008-07-10 コレジウム ファーマシューティカル, インク. 睡眠傷害のための医薬組成物
US20070203177A1 (en) * 2006-01-05 2007-08-30 Janos Hajko Forms of dolasetron mesylate and processes for their preparation
CN101774971B (zh) * 2010-02-10 2011-07-27 山东众诚药业股份有限公司 高纯度1-甲基吲唑-3-羧酸的生产方法
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB219363A (en) * 1923-03-24 1924-07-24 Abraham Preston Improvements in or in connection with bed couches
DE3650772T2 (de) * 1985-04-27 2003-04-03 F. Hoffmann-La Roche Ag, Basel Derivate von Indazole-3-carboxamide und -3-carboxylsäure
EP0330788A1 (en) * 1988-03-01 1989-09-06 Merrell Dow Pharmaceuticals Inc. Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia
GB8829079D0 (en) * 1988-12-13 1989-01-25 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
KR930000518A (ko) 1993-01-15
DK0518767T3 (da) 2002-07-01
NO305124B1 (no) 1999-04-06
EP0518767A2 (en) 1992-12-16
FI112866B (fi) 2004-01-30
DE69232473D1 (de) 2002-04-18
PT518767E (pt) 2002-09-30
KR100234926B1 (ko) 1999-12-15
ATE214392T1 (de) 2002-03-15
NO922270D0 (no) 1992-06-10
HU212735B (en) 1996-10-28
IL102132A0 (en) 1993-01-14
JPH05202044A (ja) 1993-08-10
AU649836B2 (en) 1994-06-02
NZ243031A (en) 1994-02-25
NO922270L (no) 1992-12-14
HU9201939D0 (en) 1992-08-28
IE921874A1 (en) 1992-12-16
FI922695A0 (fi) 1992-06-10
DE69232473T2 (de) 2002-11-21
IL102132A (en) 1996-10-31
EP0517984A1 (en) 1992-12-16
EP0518767A3 (en) 1993-05-05
HUT61549A (en) 1993-01-28
ES2173863T3 (es) 2002-11-01
CA2070573C (en) 2003-04-15
JP3377227B2 (ja) 2003-02-17
EP0518767B1 (en) 2002-03-13
AU1803792A (en) 1992-12-24
CA2070573A1 (en) 1992-12-12

Similar Documents

Publication Publication Date Title
FI924458L (fi) Mono-fluoriderade derivat av n-propargyl-1-amonoindan och deras anvaendning foer inhibering av monoaminoxidas
FI912605L (fi) Av skilda moduler hopsaettbar radiotelefon
FI920875L (fi) Foerfarande foer avfaergning av avfallspapper
FI920742L (fi) Foebaettrad aktovering av rekombinantproteiner
FI921149L (fi) Reaktivering av hydroformyleringskatalysatorer
FI920861L (fi) Foerfarande foer framstaellning av antitrombiniska polypeptider
FI922695L (fi) Derivat av amidanalogier av vissa kinoliziner innehaollande en metanobryggbindning
FI921308A7 (fi) Foerfarande foer framstaellning av derivat av substituerad imidazol-2-on
FI920993L (fi) Foerfarande foer framstaellning av galliumfoereningar
FI925719L (fi) Foerfarande foer framstaellning av insulinhaltiga loesningar
FI920877L (fi) Foerfarande foer utvinning av syre
FI920830L (fi) Foerfarande foer delignifiering av cellulosahaltiga raomaterialer
FI915201L (fi) Arrangemang foer styrning av en ekoslaeckare
FI88701B (fi) Foerfarande foer producering av vaeteperoxid
FI914586L (fi) Foerfarande foer foerminskning av asklasten av en cellufabriks pannanlaeggning
FI920853L (fi) Anordning foer fjaerrtestning av ledningar
FI921103L (fi) Foerfarande foer framstaellning av oxamid
FI920656A7 (fi) Foerfarande foer framstaellning av disubstituerade urea- och tioureaderivat
FI921069L (fi) Foerfarande foer diastereoselektiv reduktiv pinakolkoppling av homokirala a-aminoaldehyder
FI921862L (fi) Foerfarande foer avlaegsning av kadium av fosforsyraloesningar
FI912347L (fi) Grovinstaellning av kanalfrekvensen
FI920422L (fi) Foerfarande foer ytfoerening av kiselhalvledarskivor
FI912871L (fi) Foerfarande foer boejning av glasskivor
FI920831L (fi) Foerfarande foer delignifiering av cellulosahaltiga raomaterialer
FI920926L (fi) Foerfarande foer foerbaettring av stabiliteten foer hoegalkaliska proteaser

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: AVENTIS INC.

Free format text: AVENTIS INC.

PC Transfer of assignment of patent

Owner name: AVENTISUB II INC.

Free format text: AVENTISUB II INC.

MA Patent expired